Trials Sponsors Conditions Drugs Pricing

Conditions

Chronic Obstructive Lung Disease Neuromuscular Electrical Stimulation Pulmonary Function (FEV1/FVC)Pulmonary Rehabilitation

Outcome Measures

Primary Outcomes (3)

Six-minute walking test (Physical function assessment
The six-minute walking distance (6MWD) was measured according to a standardized protocol. * Subjects were instructed to walk at their own pace along a 34.5-m corridor from one end to the other, covering as much ground as possible in the allotted time. * Subjects were allowed to stop and rest during the test, but they were instructed to resume walking as soon as they felt able to do
change from baseline to 8 weeks after intervention and 3 months as a follow-up
Pulmonary function test
Pulmonary capacity and respiratory muscle functions will be assessed using the CPFS/D USB™ 187 Spirometer (Medical Graphics-MGC, St. Paul, MN, USA) with airflow being measured by a 188 calibrated Pitot tube (PreVent, Pneumotach). The participant completed at least three acceptable maximal forced and slow expiratory maneuvers after 15 min the inhalation of 400 mg of salbutamol 190 via a metered-dose inhaler. Forced vital capacity (FVC, L), forced expiratory volume in one second (FEV1, L), FEV1/ FVC, and inspiratory capacity (IC) will be measured according to American Thoracic Society standards
change from baseline to 8 weeks after intervention and 3 months as a follow-up
Muscle strength measurement
To determine the maximal muscle strength the Lafayette manual muscle test system (USER MANUAL) (MMT) Model 01163, White Plains, New York (10602) of gluteus maximus, quadriceps and calf muscles will be measured on right lower limb.

Secondary Outcomes (1)

Blood flow velocimetry measurement
change from baseline to 8 weeks after intervention and 3 months as a follow-up

Study Arms (2)

Control Group

ACTIVE COMPARATOR

The patients in this group were received the chest physiotherapy program for 20 min each day, for five days a week for8 consecutive weeks.

Other: Control Group Chest physical therapy

Study Group

EXPERIMENTAL

The patients in this group were received the same chest physiotherapy program combined with neuromuscular electrical stimulation (NMES) of gluteus max., quadriceps, and calf muscles performed for 30 min /day for five days a week for 8 consecutive weeks.

Other: Study Group chest physiotherapy program combined with neuromuscular electrical stimulation (NMES)

Interventions

Study Group chest physiotherapy program combined with neuromuscular electrical stimulation (NMES)Other

The patients in this group were received the same chest physiotherapy program combined with neuromuscular electrical stimulation of gluteus max., quadriceps, and calf muscles performed for 30 min /day for five days a week for 8 consecutive weeks.

Also known as: Chest physical therapy plus NMES

Study Group

Control Group Chest physical therapyOther

Eligibility Criteria

Age65 Years - 75 Years

Sexall

Healthy VolunteersNo

Age GroupsOlder Adult (65+)

You may qualify if:

A diagnosis of COPD with FEV1/FVC \<50% predicted as per the GOLD guidelines.
Self-reported dyspnea and/or arm fatigue during at least one activity of daily living that required arm exercise.

Sponsors & Collaborators

South Valley University
Othercollaborator
Beni-Suef University
Otherlead

Study Sites (1)

Department of P.T for internal medicine, Faculty of Physical Therapy, South valley university, Qena, Egypt

Qina, Egypt

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

Ibrahim I. I Abu zaid, PhD
Department of P.T for internal medicine, Faculty of Physical Therapy, South valley university, Qena, Egypt
STUDY DIRECTOR

Enrollment

60 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: DOUBLE
Who Masked: INVESTIGATOR, OUTCOMES ASSESSOR
Purpose: TREATMENT
Intervention Model: PARALLEL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: lecturer at faculty of physical therapy

Study Record Dates

First Submitted

April 2, 2023

First Posted

May 3, 2023

Study Start

April 2, 2023

Actual (reported)

Does Neuromuscular Electrical Stimulation Benefit the Functional Ability of Elderly Patients With Chronic Obstructive Lung Disease

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

Study Start

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (3)

Secondary Outcomes (1)

Study Arms (2)

Control Group

Study Group

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

Study Start

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (3)

Secondary Outcomes (1)

Study Arms (2)

Control Group

Study Group

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations